SEOUL, KOREA, April 09, 2024 (GLOBE NEWSWIRE) -- WizMedi Bio Co., Ltd.
(WizMedi Bio) today announced that it has reached a formal agreement
with the Wisconsin Alumni Research Foundation (WARF), established by the
University of Wisconsin, for the patent and technical licensing of the
A6 botulinum neurotoxin strain. This agreement enables WizMedi Bio to
prove the origin of the strain, which has been the primary hurdle to the
botulinum toxin business, and paves a pathway to develop a stable new
business in the market. ...moreShare this article on you social outlets
Our Sponsors
- - Volume: 24 - WEEK: 15 Date: 4/10/2024 3:00:43 PM -